(Q73303811)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12709021%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

A potent adjuvant effect of CD40 antibody attached to antigen (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12709021%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

10.1046/J.1365-2567.2003.01634.X

https://api.crossref.org/works/10.1046/J.1365-2567.2003.01634.X

26 December 2023

author name string

Jennifer Carlring

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12709021%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Tom A. Barr

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12709021

26 December 2023

Adele L. McCormick

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12709021

26 December 2023

Andrew W. Heath

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12709021

26 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12709021

26 December 2023

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12709021%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

2 November 2019

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2567.2003.01634.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12709021

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2567.2003.01634.x

26 December 2023

1 reference

10.1046/J.1365-2567.2003.01634.X

Crossref

DOI

https://api.crossref.org/works/10.1046/J.1365-2567.2003.01634.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2567.2003.01634.x

26 December 2023

1 reference

10.1046/J.1365-2567.2003.01634.X

Crossref

DOI

https://api.crossref.org/works/10.1046/J.1365-2567.2003.01634.X

26 December 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12709021%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12709021%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12709021%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

87-92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12709021%20AND%20SRC:MED&resulttype=core&format=json

The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb

2 November 2019

cites work

1 reference

12 December 2020

Enhancement of T cell-independent immune responses in vivo by CD40 antibodies

1 reference

12 December 2020

CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help

1 reference

12 December 2020

Enhanced in vivo immune responses to bacterial lipopolysaccharide by exogenous CD40 stimulation.

1 reference

12 December 2020

CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy

1 reference

12 December 2020

Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40

1 reference

12 December 2020

Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group

1 reference

12 December 2020

Anti-CD40 antibody enhances responses to polysaccharide without mimicking T cell help

1 reference

12 December 2020

Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb

1 reference

12 December 2020

Effective priming of cytotoxic T lymphocyte precursors by subcutaneous administration of peptide antigens in liposomes accompanied by anti-CD40 and anti-CTLA-4 antibodies

1 reference

12 December 2020

Fortifying B cells with CD154: an engaging tale of many hues

1 reference

12 December 2020

B cell immunopoiesis: visualizing the impact of CD40 engagement on the course of T cell-independent immune responses in an Ig transgenic system

1 reference

12 December 2020

Functional activity of CD40 antibodies correlates to the position of binding relative to CD154

1 reference

12 December 2020

Antibodies to CD40 induce a lethal cytokine cascade after syngeneic bone marrow transplantation.

1 reference

12 December 2020

Administration of either anti-CD40 or interleukin-12 following lethal total body irradiation induces acute lethal toxicity affecting the gut.

1 reference

12 December 2020

Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice

1 reference

12 December 2020

Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC.

1 reference

12 December 2020

Adjuvants--a balance between toxicity and adjuvanticity

1 reference

12 December 2020

The CD40 antigen and its ligand

1 reference

12 December 2020

Monoclonal antibodies to murine CD40 define two distinct functional epitopes

1 reference

12 December 2020

C3d of complement as a molecular adjuvant: bridging innate and acquired immunity

1 reference

12 December 2020

Functions of CD40 on B cells, dendritic cells and other cells

1 reference

12 December 2020

Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors

1 reference

12 December 2020